Duke Lupus Registry
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Lupus is a systemic autoimmune disease that can present with many varied symptoms, including joint pain, fevers, kidney disease, and rashes. Lupus can affect anyone, but it is most common in younger women.
The Duke Lupus Registry will collect information and blood samples from patients with lupus (systemic lupus erythematosus or cutaneous lupus) seen in the Duke Rheumatology clinics. The goal of this Registry is to understand how lupus changes over time so that we can improve the treatment of patients with lupus.
| Condition |
|---|
|
Systemic Lupus Erythematosus Cutaneous Lupus |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Duke Lupus Registry |
Blood samples will be collected for future research.
| Estimated Enrollment: | 1000 |
| Study Start Date: | July 2007 |
The Duke Lupus Registry is a prospective cohort comprised of patients with lupus seen in the Duke Rheumatology clinic.
The Duke Lupus Registry has two main purposes:
- Improved patient care. By following disease activity scores and medication usage, we expect to improve our care of the patients seen in clinic.
- Future research on lupus outcomes. This may encompass a broad array of areas, including but not limited to cardiovascular health, pregnancy and fertility, infections, medication use, quality of life, and depression.
At each office visit, patients will complete a questionnaire, physicians will measure lupus activity, and patients may be asked to provide a small blood sample. Patients will not be required to make extra visits to Duke in order to participate -- all paperwork and blood draws will occur during a regularly scheduled office visit with the physician.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Any patients with lupus.
Inclusion Criteria:
- Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus
- Patient of a rheumatologist at Duke University Medical Center
Exclusion Criteria:
- Inability to travel to Duke for follow-up visits
- Inability to speak English
- Not able to provide informed consent
Contacts and Locations| Contact: Martin Tochacek, PhD | (919) 684-5586 | martin.tochacek@duke.edu |
| United States, North Carolina | |
| Duke University Medical Center | Recruiting |
| Durham, North Carolina, United States, 27710 | |
| Contact: Martin Tochacek, PhD | |
| Sub-Investigator: Stacy Ardoin, MD | |
| Sub-Investigator: Lisa G. Criscione-Schreiber, MD | |
| Principal Investigator: Megan E. B. Clowse, MD, MPH | |
| Principal Investigator: | Megan E. B. Clowse, MD, MPH | Duke University |
More Information
Additional Information:
No publications provided
| Responsible Party: | Duke University |
| ClinicalTrials.gov Identifier: | NCT00512694 History of Changes |
| Other Study ID Numbers: | Pro00008875 (8652-07-6R1) |
| Study First Received: | August 6, 2007 |
| Last Updated: | November 11, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Duke University:
|
Lupus Systemic Lupus Erythematosus Cutaneous Lupus |
Additional relevant MeSH terms:
|
Lupus Erythematosus, Systemic Connective Tissue Diseases Autoimmune Diseases Immune System Diseases |
ClinicalTrials.gov processed this record on May 23, 2013